169 related articles for article (PubMed ID: 16083790)
1. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
Simons FE; Simons KJ
J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Simons FE;
Pediatr Allergy Immunol; 2005 Mar; 16(2):97-103. PubMed ID: 15787865
[TBL] [Abstract][Full Text] [Related]
3. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
4. A review of the role of levocetirizine as an effective therapy for allergic disease.
Walsh GM
Expert Opin Pharmacother; 2008 Apr; 9(5):859-67. PubMed ID: 18345961
[TBL] [Abstract][Full Text] [Related]
5. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study.
Hussein Z; Pitsiu M; Majid O; Aarons L; de Longueville M; Stockis A;
Br J Clin Pharmacol; 2005 Jan; 59(1):28-37. PubMed ID: 15606437
[TBL] [Abstract][Full Text] [Related]
6. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
7. Levocetirizine in the treatment of allergic diseases.
Scordamaglia F; Compalati E; Baiardini I; Scordamaglia A; Canonica GW
Expert Opin Pharmacother; 2009 Oct; 10(14):2367-77. PubMed ID: 19663743
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig.
Gupta A; Gillard M; Christophe B; Chatelain P; Massingham R; Hammarlund-Udenaes M
Br J Pharmacol; 2007 Aug; 151(7):1129-36. PubMed ID: 17558437
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
Cranswick N; Turzíkova J; Fuchs M; Hulhoven R
Int J Clin Pharmacol Ther; 2005 Apr; 43(4):172-7. PubMed ID: 15966463
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of levocetirizine on nasal mucociliary clearance in allergic rhinitis patients by rhinoscintigraphy.
Seven B; Yoruk O; Varoglu E; Sutbeyaz Y
Nucl Med Commun; 2007 Feb; 28(2):85-7. PubMed ID: 17198347
[TBL] [Abstract][Full Text] [Related]
11. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
[TBL] [Abstract][Full Text] [Related]
14. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
[TBL] [Abstract][Full Text] [Related]
15. Safety of levocetirizine treatment in young atopic children: An 18-month study.
Simons FE;
Pediatr Allergy Immunol; 2007 Sep; 18(6):535-42. PubMed ID: 17561929
[TBL] [Abstract][Full Text] [Related]
16. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
Devalia JL; De Vos C; Hanotte F; Baltes E
Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
[TBL] [Abstract][Full Text] [Related]
19. Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders.
Day JH; Ellis AK; Rafeiro E
Drugs Today (Barc); 2004 May; 40(5):415-21. PubMed ID: 15319796
[TBL] [Abstract][Full Text] [Related]
20. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria.
Dubuske LM
Allergy Asthma Proc; 2007; 28(6):724-34. PubMed ID: 18201439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
